|
|
||||||||
The Journal of Immunology, Vol 148, Issue 12 3950-3957, Copyright © 1992 by American Association of Immunologists
ARTICLES |
DL Thiele and PE Lipsky
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235.
Previous studies have demonstrated that the selective toxicity of leucyl-leucine methyl ester (Leu-Leu-OMe) for cytotoxic lymphocytes and myeloid cells is dependent on intracellular conversion to membranolytic metabolites by the acyl transferase activity of the granule enzyme dipeptidyl peptidase I (DPPI) that is enriched in these cells. The mechanism of cell death remained unclear, however, and was the subject of the experiments reported here. When human U937, HL60, or THP-1 myeloid tumor cell lines or murine CTLL-2 cells were treated with Leu- Leu-OMe, early release of both cytosolic 51Cr and soluble [3H]TdR labeled DNA fragments was observed, whereas antibody + C treatment of these cells caused only 51Cr release. Killing of U937 or THP-1 cells by incubation with the lysosomotropic amino acid methyl ester, Phe-OMe also induced only 51Cr release without evidence of DNA fragmentation. Preincubation with Zn2+, a known inhibitor of endonuclease activity prevented Leu-Leu-OMe-induced 51Cr or [3H]TdR release from these cell lines, but had no effect on antibody + C or Phe-OMe-induced 51Cr release. Zn2+ also prevented Leu-Leu-OMe-mediated killing of normal human CD16+ NK cells. Zn2+ had no inhibitory effect on Leu-Leu-OMe uptake or intracellular conversion to (Leu-Leu)n-OMe metabolites by these cell lines. Moreover, Zn2+ did not inhibit 51Cr release from nonnucleated E or nucleated U937 targets induced by extracellular production of DPPI-generated metabolites of Leu-Leu-OMe. Thus, killing of cytotoxic lymphocytes and myeloid cells by Leu-Leu-OMe appears to be dependent on generation of metabolites with membranolytic properties, but cell death induced by this process does not involve simple lysis of the plasma membrane. Rather, intracellular production of DPPI generated (Leu-Leu)n-OMe metabolites appears to trigger, an additional Zn(2+)- sensitive process that is associated with induction of apoptosis in cells with cytolytic potential.
This article has been cited by other articles:
![]() |
G. Droga-Mazovec, L. Bojic, A. Petelin, S. Ivanova, R. Romih, U. Repnik, G. S. Salvesen, V. Stoka, V. Turk, and B. Turk Cysteine Cathepsins Trigger Caspase-dependent Cell Death through Cleavage of Bid and Antiapoptotic Bcl-2 Homologues J. Biol. Chem., July 4, 2008; 283(27): 19140 - 19150. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Cirman, K. Oresic, G. D. Mazovec, V. Turk, J. C. Reed, R. M. Myers, G. S. Salvesen, and B. Turk Selective Disruption of Lysosomes in HeLa Cells Triggers Apoptosis Mediated by Cleavage of Bid by Multiple Papain-like Lysosomal Cathepsins J. Biol. Chem., January 30, 2004; 279(5): 3578 - 3587. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Grassilli, P. Salomoni, D. Perrotti, C. Franceschi, and B. Calabretta Resistance to Apoptosis in CTLL-2 Cells Overexpressing B-Myb Is Associated with B-Myb-dependent bcl-2 Induction Cancer Res., May 1, 1999; 59(10): 2451 - 2456. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Salomoni, D. Perrotti, R. Martinez, C. Franceschi, and B. Calabretta Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity PNAS, April 1, 1997; 94(7): 3296 - 3301. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Stoka, B. Turk, S. L. Schendel, T.-H. Kim, T. Cirman, S. J. Snipas, L. M. Ellerby, D. Bredesen, H. Freeze, M. Abrahamson, et al. Lysosomal Protease Pathways to Apoptosis. CLEAVAGE OF Bid, NOT PRO-CASPASES, IS THE MOST LIKELY ROUTE J. Biol. Chem., January 26, 2001; 276(5): 3149 - 3157. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |